Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1

NeuroImmunoModulation

Volumn 13, Issue 3, 2007, Pages 145-151

  Santos, Silvane B ^a,b   Porto, Aurélia F ^a   Muniz, André Luiz ^a   Luna, Tania ^a   Nascimento, Márcia C ^a   Guerreiro, Jaqueline B ^a   Oliveira Filho, Jamary ^a   Morgan, Daniel J ^d   Carvalho, Edgar M ^a,c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^c Instituto de Investigacao em Imunologia   (Brazil)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antagonists; Cytokines; HTLV 1; Interferon ; Myelopathy; T cell responses

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOMODULATION; INFLAMMATION; INTERFERON PRODUCTION; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SPINAL CORD DISEASE; VIRUS CARRIER;

AGED; CARRIER STATE; CELLS, CULTURED; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTORY, 16TH CENTURY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-15; INTERLEUKIN-2; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846582943     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097259     Document Type: Article

References (35)

1. Hollsberg P: Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 1999;63:308-333.
2. Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE: Immunological studies in tropical spastic paraparesis. Ann Neurol 1990;27:149-156.
3. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;ii:407-410.
4. Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y: Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991;29:194-201.
5. Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S: Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 2001;50:807-812.
6. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M: Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994;53:72-77.
7. Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S: Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/ tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 1998;161:482-488.
8. Carvalho EM, Bacellar O, Porto AF, Braga S, Galvao-Castro B, Neva F: Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001;27:1-6.
9. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M: Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4:586-593.
10. Tendler CL, Greenberg SJ, Blattner WA, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton JD, Nelson DL, et al: Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 1990;87:5218-5222.
11. Mariner JM, Lantz V, Waldmann TA, Azimi N: Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J Immunol 2001;166:2602-2609.
12. Biddison WE, Kubota R, Kawanishi T, Taub DD, Cruikshank WW, Center DM, Connor EW, Utz U, Jacobson S: Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997; 159:2018-2025.
13. Azimi N, Jacobson S, Leist T, Waldmann TA: Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol 1999;163:4064-4072.
14. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33: 1444-1452.
15. Izumo S, Goto I, Itoyama Y, Okajima T, Watanabe S, Kuroda Y, Araki S, Mori M, Nagataki S, Matsukura S, Akamine T, Nakagawa M, Yamamoto I, Osame M: Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 1996;46:1016-1021.
16. Buckle GJ, Hafler DA, Hollsberg P: HTLV-I-induced T-cell activation. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(suppl 1):S107-S113.
17. Nishiura Y, Nakamura T, Ichinose K, Shirabe S, Tsujino A, Goto H, Furuya T, Nagataki S: Increased production of inflammatory cytokines in cultured CD4+ cells from patients with HTLV-I-associated myelopathy. Tohoku J Exp Med 1996;179:227-233.
18. Jacobson S: Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S100-S106.
19. Osame M: Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neurovirol 2002;8:359-364.
20. Nagai M, Osame M: Human T-cell lymphotropic virus type I and neurological diseases. J Neurovirol 2003;9:228-235.
21. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-360.
22. Araujo MI, Hoppe B, Medeiros M Jr, Alcantara L, Almeida MC, Schriefer A, Oliveira RR, Kruschewsky R, Figueiredo JP, Cruz AA, Carvalho EM: Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J Infect Dis 2004;190: 1797-1803.
23. Dondi E, Rogge L, Lutfalla G, Uze G, Pellegrini S: Down-modulation of responses to type I IFN upon T cell activation. J Immunol 2003;170:749-756.
24. Strauss G, Osen W, Debatin KM: Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol 2002; 128:255-266.
25. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
26. Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ: Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element. J Biol Chem 2002;277:33766-33775.
27. Hollsberg P, Ausubel LJ, Hafler DA: Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression. J Immunol 1994;153: 566-573.
28. Germann T, Gately MK, Schoenhaut DS, Lohoff M, Mattner F, Fischer S, Jin SC, Schmitt E, Rude E: Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur J Immunol 1993;23:1762-1770.
29. Furukawa Y, Saito M, Matsumoto W, Usuku K, Tanaka Y, Izumo S, Osame M: Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/ tropical spastic paraparesis and asymptomatic HTLV-I carriers. J Infect Dis 2003;187:1116-1125.
30. Bangham CR, Osame M: Cellular immune response to HTLV-1. Oncogene 2005;24: 6035-6046.
31. La Flamme AC, Ruddenklau K, Backstrom BT: Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003;71: 4996-5004.
32. Prat A, Antel J: Pathogenesis of multiple sclerosis. Curr Opin Neurol 2005;18:225-230.
33. Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalhaes E, Melo A, Dutra WO, Gollob KJ, Carvalho EM: Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 2004;4:7.
34. Waldmann TA: T-cell receptors for cytokines: targets for immunotherapy of leukemia/ lymphoma. Ann Oncol 2000;11(suppl 1):101-106.
35. Waldmann TA: Effective cancer therapy through immunomodulation. Annu Rev Med 2006;57:65-81.